Seres Therapeutics, Inc.
MCRB
$9.31
-$0.77-7.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -75.94% | -60.67% | -68.96% | 4.36% | -29.43% |
| Total Receivables | -- | -- | 146.08% | -- | -- |
| Inventory | -- | -- | 892.45% | -- | -- |
| Prepaid Expenses | -27.78% | -32.92% | -27.03% | -51.70% | -40.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -77.95% | -65.98% | -40.59% | 42.30% | -9.94% |
|
|
|||||
| Total Current Assets | -77.95% | -65.98% | -40.59% | 42.30% | -9.94% |
| Net Property, Plant & Equipment | -14.43% | -27.49% | -9.85% | -6.33% | -19.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -88.43% | -52.21% | 146.59% | 145.52% | 274.84% |
| Total Assets | -61.01% | -51.39% | -20.83% | 26.30% | 2.81% |
|
|
|||||
| Total Accounts Payable | 12.03% | -7.86% | -62.78% | -57.56% | -79.12% |
| Total Accrued Expenses | -52.38% | -9.68% | 76.61% | 106.70% | -10.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 55.25% | 32.90% | 68.10% | 84.64% | 37.71% |
| Total Finance Division Other Current Liabilities | -73.48% | -31.22% | 45.71% | 62.14% | 71.47% |
| Total Other Current Liabilities | -73.48% | -31.22% | 45.71% | 62.14% | 71.47% |
| Total Current Liabilities | -58.22% | -18.17% | 39.00% | 54.31% | 15.26% |
|
|
|||||
| Total Current Liabilities | -58.22% | -18.17% | 39.00% | 54.31% | 15.26% |
| Long-Term Debt | -- | -- | 1.74% | 99.10% | 100.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.48% | -18.69% | -5.41% | -3.14% | -15.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.35% | -95.16% | -1.36% | 0.88% | 18.89% |
| Total Liabilities | -68.76% | -59.56% | 6.52% | 26.07% | 19.37% |
|
|
|||||
| Common Stock & APIC | 6.27% | 7.00% | 5.75% | 7.98% | 6.63% |
| Retained Earnings | 0.01% | -2.72% | -18.23% | -8.84% | -13.15% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 130.73% | 258.16% | -485.04% | -24.79% | -515.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 130.73% | 258.16% | -485.04% | -24.79% | -515.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 130.73% | 258.16% | -485.04% | -24.79% | -515.99% |
|
|
|||||